Establishment of a robust GMP-ready technology platform for large-scale Transient Gene Expression (TGE) for the manufacture of clinical grade protein pharmaceuticals
Beschreibung
The goal of this project is to establish the GMP knowledge basis and technology required to obtain eventual regulatory approval for use of TGE in manufacturing.
Eckdaten
Projektleitung
Prof. Dr. Christiane Zaborosch
Projektteam
Projektpartner
Excellgene SA
Projektstatus
abgeschlossen, 09/2009 - 12/2011
Institut/Zentrum
Institut für Chemie und Biotechnologie (ICBT)
Drittmittelgeber
KTI